FR2540500B1 - Produits derives de la mitomycine et son application au traitement des maladies neoplasiques - Google Patents

Produits derives de la mitomycine et son application au traitement des maladies neoplasiques

Info

Publication number
FR2540500B1
FR2540500B1 FR8401845A FR8401845A FR2540500B1 FR 2540500 B1 FR2540500 B1 FR 2540500B1 FR 8401845 A FR8401845 A FR 8401845A FR 8401845 A FR8401845 A FR 8401845A FR 2540500 B1 FR2540500 B1 FR 2540500B1
Authority
FR
France
Prior art keywords
treatment
application
neoplastic diseases
mitomycin derivatives
mitomycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8401845A
Other languages
English (en)
French (fr)
Other versions
FR2540500A1 (fr
Inventor
William A Remers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Patents Inc
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Patents Inc filed Critical University Patents Inc
Publication of FR2540500A1 publication Critical patent/FR2540500A1/fr
Application granted granted Critical
Publication of FR2540500B1 publication Critical patent/FR2540500B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR8401845A 1983-02-07 1984-02-07 Produits derives de la mitomycine et son application au traitement des maladies neoplasiques Expired FR2540500B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46461283A 1983-02-07 1983-02-07

Publications (2)

Publication Number Publication Date
FR2540500A1 FR2540500A1 (fr) 1984-08-10
FR2540500B1 true FR2540500B1 (fr) 1987-07-17

Family

ID=23844605

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8401845A Expired FR2540500B1 (fr) 1983-02-07 1984-02-07 Produits derives de la mitomycine et son application au traitement des maladies neoplasiques

Country Status (29)

Country Link
JP (1) JPS59152384A (de)
KR (1) KR900006854B1 (de)
AT (1) AT385509B (de)
AU (1) AU571193B2 (de)
BE (1) BE898856A (de)
CA (1) CA1252789A (de)
CH (1) CH658658A5 (de)
DD (1) DD233844A5 (de)
DE (1) DE3403922A1 (de)
DK (1) DK161890C (de)
ES (1) ES8607305A1 (de)
FI (1) FI80698C (de)
FR (1) FR2540500B1 (de)
GB (1) GB2134514B (de)
GR (1) GR81455B (de)
HU (1) HU190236B (de)
IE (1) IE56814B1 (de)
IL (1) IL70897A (de)
IT (1) IT1178855B (de)
LU (1) LU85199A1 (de)
NL (1) NL8400338A (de)
NO (1) NO161374C (de)
NZ (1) NZ206932A (de)
OA (1) OA07654A (de)
PH (1) PH20249A (de)
PT (1) PT78067B (de)
SE (1) SE461982B (de)
YU (1) YU44984B (de)
ZA (1) ZA84788B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487769A (en) * 1982-06-04 1984-12-11 Bristol-Myers Company Amidines
CA1282069C (en) * 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
JPS63150282A (ja) * 1986-12-13 1988-06-22 Kyowa Hakko Kogyo Co Ltd マイトマイシン誘導体
JPS63246379A (ja) * 1987-03-31 1988-10-13 Kyowa Hakko Kogyo Co Ltd ７−ｎ，８−ｎ−エチレンマイトマイシン８−イミン類
EP0485904B1 (de) * 1990-11-13 1997-08-20 Kyowa Hakko Kogyo Co., Ltd. Mitomycinderivate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3332944A (en) * 1964-11-02 1967-07-25 American Cyanamid Co Antibiotic derivatives of mitomycins a, b, c and porfiromycin
JPS5439098A (en) * 1977-08-31 1979-03-24 Kyowa Hakko Kogyo Co Ltd Mitomycin c derivatives
US4268676A (en) * 1979-12-05 1981-05-19 University Patents, Inc. Mitomycin analogs
JPS5686184A (en) * 1979-12-17 1981-07-13 Kyowa Hakko Kogyo Co Ltd Novel mitomycin c derivative
NZ199617A (en) * 1981-05-15 1985-08-30 University Patents Inc Azirino(2',3',:3,4)pyrrolo(1,2-a)indole-4,7-dione derivatives and pharmaceutical compositions
US4487769A (en) * 1982-06-04 1984-12-11 Bristol-Myers Company Amidines
US4642352A (en) * 1983-12-23 1987-02-10 Bristol-Myers Company Acylamino mitosanes

Also Published As

Publication number Publication date
FI80698C (fi) 1990-07-10
ATA37684A (de) 1987-09-15
ES529478A0 (es) 1986-05-16
ZA84788B (en) 1984-09-26
CA1252789A (en) 1989-04-18
IE840272L (en) 1984-08-07
ES8607305A1 (es) 1986-05-16
GB8402233D0 (en) 1984-02-29
PT78067A (en) 1984-03-01
JPS59152384A (ja) 1984-08-31
OA07654A (fr) 1985-05-23
NZ206932A (en) 1987-08-31
GB2134514B (en) 1987-04-01
AU2407384A (en) 1984-08-16
HU190236B (en) 1986-08-28
IL70897A0 (en) 1984-05-31
NO161374C (no) 1989-08-09
FI840502A0 (fi) 1984-02-07
IL70897A (en) 1989-01-31
FI80698B (fi) 1990-03-30
IT1178855B (it) 1987-09-16
IE56814B1 (en) 1991-12-18
KR840007726A (ko) 1984-12-10
AU571193B2 (en) 1988-04-14
GR81455B (de) 1984-12-11
GB2134514A (en) 1984-08-15
PT78067B (en) 1986-03-20
FI840502A (fi) 1984-08-08
DK161890B (da) 1991-08-26
DD233844A5 (de) 1986-03-12
YU21784A (en) 1986-10-31
SE8400628D0 (sv) 1984-02-07
NL8400338A (nl) 1984-09-03
SE8400628L (sv) 1984-08-08
AT385509B (de) 1988-04-11
DK52484A (da) 1984-08-08
DE3403922A1 (de) 1984-08-09
BE898856A (fr) 1984-05-30
FR2540500A1 (fr) 1984-08-10
KR900006854B1 (ko) 1990-09-22
LU85199A1 (fr) 1984-05-30
SE461982B (sv) 1990-04-23
DK161890C (da) 1992-02-03
CH658658A5 (de) 1986-11-28
YU44984B (en) 1991-06-30
IT8467113A0 (it) 1984-02-07
NO840433L (no) 1984-08-08
PH20249A (en) 1986-11-10
NO161374B (no) 1989-05-02
DK52484D0 (da) 1984-02-06

Similar Documents

Publication Publication Date Title
ATA242288A (de) Dosierungsform für die behandlung kardiovaskulärer erkrankungen
DE3885419D1 (de) Für die direkte Expression von aktiviertem menschlichen Protein-C verwendbare Vektoren und Zusammensetzungen.
NO911952L (no) Behandling av tilstander og sykdommer samt midler derfor.
NO894296L (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
IT8147516A0 (it) Apparecchio e procedimento per il frazionamento di miscele di proteine
FR2576752B1 (fr) Procede de purification de proteines du lait et de ses derives
FR2499414B1 (fr) Production d'anticorps proteiniques humains
ES2022648B3 (es) Perfeccionamiento de tamiz para depuradores y su modo de fabricacion
BR8800204A (pt) Processamento de material de tabaco
MC1998A1 (fr) Composes pour le traitement des maladies hyperproliferatibes et procede de preparation
FR2569697B1 (fr) Produits derives de la mitomycine et leur application au traitement de maladies neoplasiques
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
DE3780506D1 (de) Reinigung des einkettigen und zweikettigen gewebeplasminogenaktivators.
FR2540500B1 (fr) Produits derives de la mitomycine et son application au traitement des maladies neoplasiques
IL88758A0 (en) Vector and compounds for expression of zymogen forms of human protein c
DE3471482D1 (de) Amide derivatives of azabicycloalkanes
NO973193D0 (no) Kollagen-baserte metoder og formuleringer for behandling av immune system-medierte sykdommer
DE68902354D1 (de) Verfahren zum steigern der produktivitaet in mutterschweinen.
PT88436A (pt) Process for the preparation of modified plasminogen activators
FR2611201B1 (fr) Intermediaires de tetrazole et procede de preparation de derives antihypercholesterolemiques du tetrazole
IT1178123B (it) Apparecchio per la bagnatura e lo sfregamento intenso di cereali
IT8348722A0 (it) Procedimento per la produzione e la immobilizzazione di proteine modificate
IT1206075B (it) Frangitore-molitore per olive, cereali e simili
IT8347926A0 (it) Prodotto di erboristeria per la cura delle emorroidi ed altre infiammazioni
PL266663A1 (en) Method of obtaining diaminobenzene anilide and its derivatives

Legal Events

Date Code Title Description
ST Notification of lapse